Expert consensus on precision detection of intrahepatic cholangiocarcinoma (2024 edition)
10.12025/j.issn.1008-6358.2025.20241538
- VernacularTitle:肝内胆管癌精准检测专家共识（2024版）
- Author:
, Shanghai 200032, China PATHOLOGY GROUP, CHINESE SOCIETY OF LIVER CANCER OF CHINESE ANTI-CANCER ASSOCIATION
1
;
LIVER PATHOLOGY GROUP, CHINESE SOCIETY OF PATHOLOGY OF CHINESE ANTI-CANCER ASSOCIATION
;
TUMOR PATHOLOGY COMMITTEE OF SHANGHAI ANTI-CANCER ASSOCIATION
1
Author Information
1. .
- Publication Type:Standardandguideline
- Keywords:
intrahepatic cholangiocarcinoma;
precision detection;
biomarker;
personalized treatment
- From:
Chinese Journal of Clinical Medicine
2025;32(1):145-160
- CountryChina
- Language:Chinese
-
Abstract:
Intrahepatic cholangiocarcinoma (ICC) is a highly heterogeneous tumor, and molecular profiling serves as the foundation for personalized treatment of ICC. Accurate detection methods are clinically significant for comprehensively screening patients suitable for targeted therapies. This consensus is based on clinical practice data from both domestic and international sources, tailored to the Chinese context, and focuses on key targets for ICC. We present 15 recommendations aimed at guiding the precision detection of ICC.
